These are the key facts and figures within the life sciences industry. Information ranges from the top performing countries in life sciences particularly in biotechnology and healthcare (biomedical and pharmaceutical). In addition, it addresses R&D expenditures by key countries from the year 2008 to 2016.

1. Key Facts & Figures
in the Life Sciences Industry
By Xeraya Capital

2. Top Performing Countries in Life Sciences Research
(as at 2015)
# Country Nature Index
1 USA 7616.7
2 UK 1207.31
3 Germany 1036.32
4 China 733.18
5 Japan 664.15
6 Canada 578.21
7 France 572.56
8 Australia 312.94
9 Switzerland 311.01
10 Spain 239.57
Source: https://www.natureindex.com/annual-tables/2016/country/life-sciences

3. The World's Best Countries in Science
What makes one country
better than another in
science?
Publishing research papers is a
good way to get a bead on basic
research, but it doesn't say much
about whether a nation is taking
advantage of those good ideas.
For this, other metrics come into
play: Patents give a clue as to how
well a country is exploiting its ideas
for commercial gain.
What a nation spends on R&D
captures not only what universities
and government research
programs do but also the
contribution from industry.

4. The World's Best Countries in Science
# Country
1 USA
2 Japan
3 Germany
4 South Korea
5 Taiwan
Top 5 by Patents
# Country
1 USA
2 China
3 Japan
4 Germany
5 France
Top 5 by Expenditure
# Country
1 China
2 USA
3 Germany
4 UK
5 France
Top 5 by PhDs Awarded
Source: https://www.scientificamerican.com/article/the-worlds-best-countries-science/

5. DID YOU KNOW?
Source: https://www.dcatvci.org/11-value-chain-insights/250-biopharmaceutical-innovation-which-countries-rank-the-best
Although the US produces
about 22% of the global GDP
and accounts for 4% of the
world's population, it accounts
for 44% of global biomedical
R&D expenditures and its
domestic pharmaceutical
market about 40% of the global
market.

6. Ranking by Total Biotechnology
R&D companies & Expenditures
The United States ranks first in the
number of biotech firms, PCT
patent applications, and
biomedical treatment approvals,
with Spain coming second,
according to the 2015 OECD report
on biotechnology statistics.
According to the report, the U.S.
has 11,367 biotech firms followed by
2,831 in Spain and 1,950 in France.
Source: https://www.thebalance.com/ranking-the-top-biotech-countries-3973287

7. Ranking by Total Biotechnology
R&D companies & Expenditures
They are followed by Korea,
Germany, United Kingdom, Japan,
Mexico, New Zealand and Belgium
rounding out the top 10.
Small biotech firms are the rule
rather than the exception, with 72
percent of the biotechnology firms
in the United States having 50 or
fewer employees.
Source: https://www.thebalance.com/ranking-the-top-biotech-countries-3973287

8. Ranking by Total Biotechnology
R&D companies & Expenditures
The number of firms is one way to
rank biotech by country, while
expenditures in research and
development are another.
The United States outspends France
8 to 1, around $27 billion to a little
over $3 billion in 2012.
Other big spenders include
Switzerland, Korea, Japan,
Germany, and Denmark at all over
one billion dollars.
Source: https://www.thebalance.com/ranking-the-top-biotech-countries-3973287

9. The Changing Landscape for
Research and Development
R&D budgets have felt the squeeze
in the European Union, Japan, and
the United States since 2008, with
only 1.6% annual growth rate on
average in 2008 through 2012.
Meanwhile, China continues to
boost its spending on R&D in
general, doubling it between 2008
and 2012.
Source: https://www.thebalance.com/ranking-the-top-biotech-countries-3973287

10. The Changing Landscape for
Research and Development
It’s expected that China will be the
leading spender in R&D by 2019,
according to OECD. Beyond
Borders: Global Biotechnology
Report by Ernst and Young,
indicates that China and India rank
as the top 2 countries for increasing
gross domestic product (GDP).
Source: https://www.thebalance.com/ranking-the-top-biotech-countries-3973287

11. The Shift to Asia
China will soon become the 3rd
largest pharmaceutical market
after the USA and Japan, and,
being a popular (inexpensive) spot
for outsourcing, will do well in
coming years. India also benefitted
from downsizing and cost-cutting
in other nations during the
recession, due to its highly skilled
workforce and lower
manufacturing and research costs.
Source: https://www.thebalance.com/ranking-the-top-biotech-countries-3973287

12. TOP 5 BIOTECH COMPANIES
$[VALUE]b
$[VALUE]b
$[VALUE]b
$[VALUE]b
$[VALUE]b
0 20 40 60 80 100 120 140
Biogen
Celgene
Novo Nordisk
Gilead Sciences
Amgen Highly differentiated medicines addressing serious diseases
Medicines for major diseases such as HIV/AIDS, Liver, blood, cancer, cardiovascular, etc.
Diabetes care, hormone replacement
Medicines for cancer and inflammatory disorders
Therapies for neurodegenerative, hematologic &
autoimmune diseases

13. 1. https://www.natureindex.com/annual-tables/2016/country/life-sciences
2. https://www.scientificamerican.com/article/the-worlds-best-countries-science/
3. https://www.dcatvci.org/11-value-chain-insights/250-biopharmaceutical-innovation-which-countries-rank-the-best
4. https://www.thebalance.com/ranking-the-top-biotech-countries-3973287
References: